The consensus price target hints at a 63.6% upside potential for Oruka Therapeutics, Inc. (ORKA). Wh...
MENLO PARK, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: OR...
Guggenheim assumed coverage on Oruka Therapeutics in a research note on Monday. They set a "buy" rat...
Oruka Therapeutics, Inc. (NASDAQ: ORKA) is increasingly capturing the attention of savvy investors, ...
Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) have been assigned an average rat...